Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Hims & Hers Health Inc. shares slid over 2.8% on Tuesday and continued declining after-hours trading after Eli Lilly ...

Eli Lilly (NYSE:LLY) announced a significant global licensing and research collaboration with Juvena Therapeutics to explore ...

Rosnilimab met key RA trial goals, with sustained clinical responses and safety benefits, prompting an analyst upgrade and price target hike to $38. Vandana Singh Mounjaro Maker Eli Lilly Taps ...

Positive results for Eli Lilly's new diabetes and weight-loss drug have recently boosted its stock price. Data from several studies on the GLP-1 drug are expected to come out this year.

And when you're looking even further ahead, at the next five years, the valuation may be even more justifiable as Eli Lilly stock trades at a price/earnings-to-growth (PEG) multiple of around 0.75.

Eli Lilly shares dropped more than 4% on ... Week's 50% Surge—Watch These Key Levels Watch These D-Wave Price Levels as Quantum Computing Stock Soars on Next-Gen Launch ...

Tuesday, Eli Lilly and Company (NYSE: LLY) stock maintained its Buy rating and a price target of $1,050.00, as reiterated by UBS analysts.According to InvestingPro data, the pharmaceutical giant ...

This was the stock's third consecutive day of gains.

Eli Lilly (LLY) Stock Price Prediction in 2025 The current Wall Street consensus 1-year price target of Eli Lilly stock is $1030.00, which is 36.07% higher than today’s price of $756.99.